Company Filing History:
Years Active: 2016-2022
Title: Inventor Spotlight: Engin Toksoz
Introduction
Engin Toksoz is an accomplished inventor based in Munich, Germany, renowned for his contributions to the field of biotechnology. With a remarkable portfolio of three patents, he has made significant advancements in antibody technology that hold great potential for therapeutic applications.
Latest Patents
Among his notable inventions is a patent related to anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules. This innovative work provides a detailed disclosure of anti-BTC antibodies, methods for their production, pharmaceutical compositions, and applications. Furthermore, this patent encompasses multi-specific binding molecules, such as bispecific antibodies, which combine a BTC binding moiety with an anti-VEGF binding moiety. Another significant patent focuses on antibody drug conjugates, specifically anti-FGFR2 and FGFR4 antibodies. This invention includes antibody fragments and conjugates designed for the treatment of cancer, positioning Toksoz at the forefront of oncological research.
Career Highlights
Engin Toksoz has built his career at Novartis AG, a global leader in pharmaceuticals. His expertise in the development of innovative antibody therapies showcases his dedication to enhancing treatment options for patients. His work is characterized by a focus on translational research that bridges laboratory findings with clinical applications.
Collaborations
Throughout his career, Toksoz has collaborated with notable colleagues, including Nicole Haubst and David Bryant Batt. These collaborations enhance his research capabilities, enabling him to leverage diverse expertise in advancing therapeutic solutions for complex medical challenges.
Conclusion
Engin Toksoz exemplifies the spirit of innovation in the biotechnology sector. His contributions through patented inventions are poised to make a lasting impact on the treatment of various conditions, especially in cancer therapy. With a commitment to excellence and collaboration, Toksoz continues to pave the way for future advancements in medical science.